NHS National Framework Agreement for the supply of Recombinant Factor X and Porcine Factor VIII for the treatment of bleeding disorders
key details
| Value | £4,400,000 |
|---|---|
| Status | cancelled |
| Category (CPV) | 33141000 +1 more |
| Deadline | 18 Apr 2016 |
| Contract start | 1 Jul 2016 |
| Contract end | 30 Jun 2017 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-6e82baa3-adc9-11e6-9901-0019b9f3037b |
description
NHS National framework agreement for the supply of Recombinant Factor X and Porcine Factor VIII for the treatment of bleeding disorders. The framework will commence on 1.7.2016 to 31.6.2017 with options to extend for up to a further 36 months.
Please refer to the Invitation to offer, Document No.05d for a list of the Participating Authorities.
documents
- https://www.contractsfinder.service.gov.uk/Notice/383b2dcb-3a15-43e0-883b-4cf690867a21 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/27ad4a78-551b-4093-82be-9dc6222f2563 , application/pdf
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/468b7e93-5291-4e73-99b3-8eda41de3433 , application/x-zip-compressed
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/6be21637-71e3-4552-9a7f-dd491f6e2d65 , application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 18 Nov 2016 | Tender cancelled (tenderCancellation) | · | 383b2dcb-3a15-43e0-883b-4cf690867a21-90713 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Laboratory Consumables · University of Portsmouth Higher Education Corporation
- Trocars · University Hospitals of Leicester NHS Trust · £922,924
- BIS Monitoring · East Sussex Healthcare NHS Trust · £193,575
- Central Venous Catheters and Associated Products · Supply Chain Coordination Limited · £136,500,000
- Provision of Crime Scene Consumables and DNA Kits · The Police and Crime Commissioner for Humberside · £215,000
- Blood Collection Devices · Supply Chain Coordination Limited · £244,000,000
- Human Derived Blood Products · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £69,978,867
- Vascular Therapy · Dorset County Hospital NHS Foundation Trust · £34,184
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.